Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Prevalence of SARS-CoV-2 antibodies in a large nationwide sample of patients on dialysis in the USA: a cross-sectional study
Shuchi Anand, Maria E. Montez‐Rath, Jialin Han, et al.
The Lancet (2020) Vol. 396, Iss. 10259, pp. 1335-1344
Open Access | Times Cited: 297

Showing 26-50 of 297 citing articles:

SARS-CoV-2 Infection Is at Herd Immunity in the Majority Segment of the Population of Qatar
Mohamed H. Al‐Thani, Elmoubasher Farag, Roberto Bertollini, et al.
Open Forum Infectious Diseases (2021) Vol. 8, Iss. 8
Open Access | Times Cited: 76
The Main Molecular and Serological Methods for Diagnosing COVID-19: An Overview Based on the Literature
Bruna Aparecida Souza Machado, Katharine Valéria Saraiva Hodel, Valdir Barbosa-Júnior, et al.
Viruses (2020) Vol. 13, Iss. 1, pp. 40-40
Open Access | Times Cited: 70
COVID-19 and kidney disease: insights from epidemiology to inform clinical practice
Viyaasan Mahalingasivam, Guobin Su, Masao Iwagami, et al.
Nature Reviews Nephrology (2022) Vol. 18, Iss. 8, pp. 485-498
Open Access | Times Cited: 65
Has the COVID-19 pandemic lockdown worsened eating disorders symptoms among patients with eating disorders? A systematic review
Yunqi Gao, Nasser Bagheri, Luis Furuya‐Kanamori
Journal of Public Health (2022) Vol. 30, Iss. 11, pp. 2743-2752
Open Access | Times Cited: 65
SARS-CoV-2 infection hospitalization, severity, criticality, and fatality rates in Qatar
Shaheen Seedat, Hiam Chemaitelly, Houssein H. Ayoub, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 64
Evaluation of Commercially Available High-Throughput SARS-CoV-2 Serologic Assays for Serosurveillance and Related Applications
Mars Stone, Eduard Grebe, Hasan Sulaeman, et al.
Emerging infectious diseases (2022) Vol. 28, Iss. 3, pp. 672-683
Open Access | Times Cited: 58
Clinical and Economic Effects of Widespread Rapid Testing to Decrease SARS-CoV-2 Transmission
A. David Paltiel, Amy Zheng, Paul E. Sax
Annals of Internal Medicine (2021) Vol. 174, Iss. 6, pp. 803-810
Open Access | Times Cited: 57
Infection fatality rate of COVID-19 in community-dwelling elderly populations
Cathrine Axfors, John P. A. Ioannidis
European Journal of Epidemiology (2022) Vol. 37, Iss. 3, pp. 235-249
Open Access | Times Cited: 54
Neighborhood socioeconomic inequality based on everyday mobility predicts COVID-19 infection in San Francisco, Seattle, and Wisconsin
Brian L. Levy, Karl Vachuska, S. V. Subramanian, et al.
Science Advances (2022) Vol. 8, Iss. 7
Open Access | Times Cited: 52
Estimated SARS-CoV-2 antibody seroprevalence trends and relationship to reported case prevalence from a repeated, cross-sectional study in the 50 states and the District of Columbia, United States—October 25, 2020–February 26, 2022
Ryan E. Wiegand, Yangyang Deng, Xiaoyi Deng, et al.
The Lancet Regional Health - Americas (2022) Vol. 18, pp. 100403-100403
Open Access | Times Cited: 44
COVID-19 prevalence and mortality in longer-term care facilities
Andrew Levin, Juulia Jylhävä, Dorota Religa, et al.
European Journal of Epidemiology (2022) Vol. 37, Iss. 3, pp. 227-234
Open Access | Times Cited: 38
Impact of COVID-19 vaccination: a global perspective
Priya Singh, Aditya Anand, Shweta Rana, et al.
Frontiers in Public Health (2024) Vol. 11
Open Access | Times Cited: 10
Assessing the Age Specificity of Infection Fatality Rates for COVID-19: Systematic Review, Meta-analysis, & Public Policy Implications
Andrew Levin, William P. Hanage, Nana Owusu‐Boaitey, et al.
(2020)
Open Access | Times Cited: 65
Assessing the Age Specificity of Infection Fatality Rates for COVID-19: Systematic Review, Meta-Analysis, and Public Policy Implications
Andrew Levin, William P. Hanage, Nana Owusu‐Boaitey, et al.
medRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 61
Rapid decline of neutralizing antibodies is associated with decay of IgM in adults recovered from mild COVID-19
Whitney E. Harrington, Olesya Trakhimets, Daniela V. Andrade, et al.
Cell Reports Medicine (2021) Vol. 2, Iss. 4, pp. 100253-100253
Open Access | Times Cited: 54
At least 156 reasons to prioritize COVID-19 vaccination in patients receiving in-centre haemodialysis
Christian Combe, Alexander H. Kirsch, Gaetano Alfano, et al.
Nephrology Dialysis Transplantation (2021) Vol. 36, Iss. 4, pp. 571-574
Open Access | Times Cited: 50
Adapting Serosurveys for the SARS-CoV-2 Vaccine Era
Nathan Duarte, Mercedes Yanes‐Lane, Rahul K. Arora, et al.
Open Forum Infectious Diseases (2021) Vol. 9, Iss. 2
Open Access | Times Cited: 48
Optimal allocation of limited vaccine to control an infectious disease: Simple analytical conditions
Isabelle J. Rao, Margaret L. Brandeau
Mathematical Biosciences (2021) Vol. 337, pp. 108621-108621
Open Access | Times Cited: 43
Use of US Blood Donors for National Serosurveillance of Severe Acute Respiratory Syndrome Coronavirus 2 Antibodies: Basis for an Expanded National Donor Serosurveillance Program
Mars Stone, Clara Di Germanio, David J. Wright, et al.
Clinical Infectious Diseases (2021) Vol. 74, Iss. 5, pp. 871-881
Open Access | Times Cited: 42
Incidence and Clinical Impacts of COVID-19 Infection in Patients with Hemodialysis: Systematic Review and Meta-Analysis of 396,062 Hemodialysis Patients
Chun‐Yu Chen, Shih‐Chieh Shao, Yih-Ting Chen, et al.
Healthcare (2021) Vol. 9, Iss. 1, pp. 47-47
Open Access | Times Cited: 41
Stochastic social behavior coupled to COVID-19 dynamics leads to waves, plateaus, and an endemic state
Alexei V. Tkachenko, Sergei Maslov, Tong Wang, et al.
eLife (2021) Vol. 10
Open Access | Times Cited: 41
Estimates of global SARS-CoV-2 infection exposure, infection morbidity, and infection mortality rates in 2020
Houssein H. Ayoub, Ghina R. Mumtaz, Shaheen Seedat, et al.
Global Epidemiology (2021) Vol. 3, pp. 100068-100068
Open Access | Times Cited: 41
Risk of SARS-CoV-2 reinfection: a systematic review and meta-analysis
Luojia Deng, Peiqi Li, Xuezhixing Zhang, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 34
Social Vulnerability and Rurality Associated With Higher Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection–Induced Seroprevalence: A Nationwide Blood Donor Study—United States, July 2020–June 2021
Zheng Li, Brian Lewis, Kevin Berney, et al.
Clinical Infectious Diseases (2022) Vol. 75, Iss. 1, pp. e133-e143
Open Access | Times Cited: 32
COVID-19 and Kidney Disease
Maureen Brogan, Michael J. Ross
Annual Review of Medicine (2022) Vol. 74, Iss. 1, pp. 1-13
Open Access | Times Cited: 32

Scroll to top